Ignite Creation Date:
2025-12-24 @ 10:23 PM
Ignite Modification Date:
2026-02-26 @ 6:53 AM
Study NCT ID:
NCT00371735
Status:
COMPLETED
Last Update Posted:
2016-12-05
First Post:
2006-09-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Chlorproguanil-Dapsone-Artesunate (CDA) Versus Chlorproguanil-Dapsone (LAPDAP) For Uncomplicated Malaria
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-04
Start Date Type:
None
Primary Completion Date:
2007-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-05
Completion Date Type:
ACTUAL
First Submit Date:
2006-09-01
First Submit QC Date:
None
Study First Post Date:
2006-09-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-12-02
Last Update Post Date:
2016-12-05
Last Update Post Date Type:
ESTIMATED